1997
Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs
Muga R, Roca J, Tor J, Pigem C, Rodriguez R, Egea J, Vlahov D, Muñoz A. Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs. International Journal Of STD & AIDS 1997, 8: 225-228. PMID: 9147154, DOI: 10.1258/0956462971919967.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusRapid plasma reagentEnzyme-linked immunosorbent assaySerologic syphilisDrug usersSex partnersHigh-risk sexual behaviorCross-sectional analysisGender-specific differencesMale IDUsHIV infectionImmunodeficiency virusFemale IDUsSexual transmissionTreponemal testsReactive samplesSyphilisSexual partnersWestern blotImmunosorbent assayIDUsPlasma reagentWomenSexual behaviorMen
1996
Differences in the Incidence of Hepatitis B and Human Immunodeficiency Virus Infections among Injecting Drug Users
Levine O, Vlahov D, Brookmeyer R, Cohn S, Nelson K. Differences in the Incidence of Hepatitis B and Human Immunodeficiency Virus Infections among Injecting Drug Users. The Journal Of Infectious Diseases 1996, 173: 579-583. PMID: 8627020, DOI: 10.1093/infdis/173.3.579.Peer-Reviewed Original ResearchConceptsHepatitis B virusHBV seroconversionOutcome measuresDrug usersHuman immunodeficiency virus type 1 (HIV-1) seroconversionIncident hepatitis B virusHuman immunodeficiency virus (HIV) infectionHIV seroconversion ratesHIV-seronegative IDUsSubsequent HIV seroconversionImmunodeficiency virus infectionInjecting Drug UsersSurrogate outcome measureImportant outcome measureNeedle exchange programsMale IDUsHIV seroconversionIncident HIVSeroconversion ratesHepatitis BHIV infectionFemale IDUsB virusVirus infectionSeroconversion